These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19582394)

  • 1. WNT/beta-catenin increases the production of incretins by entero-endocrine cells.
    García-Martínez JM; Chocarro-Calvo A; Moya CM; García-Jiménez C
    Diabetologia; 2009 Sep; 52(9):1913-24. PubMed ID: 19582394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin drives glucose-dependent insulinotropic peptide expression via glucose-dependent regulation of FoxO1 and LEF1/β-catenin.
    García-Martínez JM; Chocarro-Calvo A; De la Vieja A; García-Jiménez C
    Biochim Biophys Acta; 2014 Nov; 1839(11):1141-50. PubMed ID: 25091498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling.
    Rao AS; Kremenevskaja N; Resch J; Brabant G
    Eur J Endocrinol; 2005 Dec; 153(6):929-38. PubMed ID: 16322400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor.
    Dong YF; Soung do Y; Schwarz EM; O'Keefe RJ; Drissi H
    J Cell Physiol; 2006 Jul; 208(1):77-86. PubMed ID: 16575901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways.
    Friedrichsen BN; Neubauer N; Lee YC; Gram VK; Blume N; Petersen JS; Nielsen JH; Møldrup A
    J Endocrinol; 2006 Mar; 188(3):481-92. PubMed ID: 16522728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of human incretin receptor missense variants.
    Fortin JP; Schroeder JC; Zhu Y; Beinborn M; Kopin AS
    J Pharmacol Exp Ther; 2010 Jan; 332(1):274-80. PubMed ID: 19841474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice.
    Moriya R; Shirakura T; Ito J; Mashiko S; Seo T
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1358-65. PubMed ID: 19808907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric inhibitory polypeptide analogues: do they have a therapeutic role in diabetes mellitus similar to that of glucagon-like Peptide-1?
    Holst JJ
    BioDrugs; 2002; 16(3):175-81. PubMed ID: 12102645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1.
    Pathak V; Vasu S; Flatt PR; Irwin N
    Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
    Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incretin hormones in the treatment of type 2 diabetes. Part I: influence of insulinotropic gut-derived hormones (incretins) on glucose metabolism].
    Matuszek B; Lenart-Lipińska M; Nowakowski A
    Endokrynol Pol; 2007; 58(6):522-8. PubMed ID: 18205109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incretin hormones regulate microglia oxidative stress, survival and expression of trophic factors.
    Spielman LJ; Gibson DL; Klegeris A
    Eur J Cell Biol; 2017 May; 96(3):240-253. PubMed ID: 28336086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pax6 and Pdx1 are required for production of glucose-dependent insulinotropic polypeptide in proglucagon-expressing L cells.
    Fujita Y; Chui JW; King DS; Zhang T; Seufert J; Pownall S; Cheung AT; Kieffer TJ
    Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E648-57. PubMed ID: 18593849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
    Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
    J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity.
    Gault VA; Kerr BD; Harriott P; Flatt PR
    Clin Sci (Lond); 2011 Aug; 121(3):107-17. PubMed ID: 21332446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel extrapancreatic effects of incretin.
    Yamada Y; Tsukiyama K; Sato T; Shimizu T; Fujita H; Narita T
    J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):76-9. PubMed ID: 27186360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.
    Mayer F; Gunawan AL; Tso P; Aponte GW
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G23-G35. PubMed ID: 32421358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression and function of glucose-dependent insulinotropic polypeptide in the embryonic mouse pancreas.
    Prasadan K; Koizumi M; Tulachan S; Shiota C; Lath N; Paredes J; Guo P; El-Gohary Y; Malek M; Shah S; Gittes GK
    Diabetes; 2011 Feb; 60(2):548-54. PubMed ID: 21270265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.
    Skow MA; Bergmann NC; Knop FK
    Diabetes Obes Metab; 2016 Sep; 18(9):847-54. PubMed ID: 27160961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.